Silencing of circ-0031242 mitigates cisplatin (DDP) resistance and inhibits the proliferation, invasion, and migration of DDP-resistant HCC cells through the miR-924/POU class 3 homeobox 2 (POU3F2) axis (79). This evidence concerns the gene POU3F2 and hepatocellular carcinoma.